Post-approval studies (Phase 4)Study completedNCT01169701
What this trial is testing
24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients
Who this might be right for
Renal Transplant
Novartis Pharmaceuticals 71